BC
LLY icon

Barrett & Company’s Eli Lilly LLY Stock Holding History

Barrett & Company’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Buy
984
+464
+89% +$474K 0.33% 45
2026
Q1 		$478K Buy
520
+4
+0.8% +$4.05K 0.16% 85
2025
Q4 		$555K Sell
516
-6
-1% -$5.74K 0.19% 81
2025
Q3 		$398K Sell
522
-221
-30% -$164K 0.14% 93
2025
Q2 		$579K Buy
743
+3
+0.4% +$2.33K 0.22% 74
2025
Q1 		$611K Buy
740
+1
+0.1% +$832 0.26% 68
2024
Q4 		$571K Buy
739
+3
+0.4% +$2.48K 0.24% 71
2024
Q3 		$652K Sell
736
-316
-30% -$284K 0.28% 64
2024
Q2 		$953K Buy
1,052
+1
+0.1% +$800 0.43% 43
2024
Q1 		$818K Buy
1,051
+267
+34% +$190K 0.39% 49
2023
Q4 		$457K Sell
784
-338
-30% -$197K 0.25% 79
2023
Q3 		$602K Buy
1,122
+9
+0.8% +$4.64K 0.35% 58
2023
Q2 		$522K Buy
1,113
+2
+0.2% +$839 0.3% 66
2023
Q1 		$381K Buy
1,111
+4
+0.4% +$1.35K 0.24% 82
2022
Q4 		$405K Hold
1,107
– – 0.27% 76
2022
Q3 		$405K Buy
+1,107
New +$351K 0.27% 76

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Barrett & Company's LLY Position: Q2 2026 in Review

Barrett & Company increased its Eli Lilly (LLY) stake by 89% in Q2 2026, buying an estimated $474K and bringing the position to 984 shares worth $1.18M. The position accounts for 0.33% of the portfolio, ranked #45.

Barrett & Company first reported a position in LLY in Q3 2022 and has held it in 16 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Barrett & Company held 984 shares of Eli Lilly worth $1.18M as of Q2 2026.
  • Barrett & Company bought 464 Eli Lilly shares in Q2 2026, an estimated $474K.
  • Eli Lilly made up 0.33% of Barrett & Company's portfolio in Q2 2026, its #45 holding.
  • Barrett & Company first reported a position in Eli Lilly in Q3 2022 and has held it in 16 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Barrett & Company's 13F filing for Q2 2026, filed 24 Jul 2026.